This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Understanding the Landscape of Type-2 Diabetes Treatments and the prevalence of Lilly's Mounjaro.

Ticker(s): LLY, NVO

Who's the expert?

Institution: University of Texas Medical Branch

  • Associate Director, Endocrinology Fellowship Program, Asst Prof (N-T Trk Clin), Internal medicine at UTMB.
  • Treats 600 patients with Type-2 Diabetes.

Interview Questions
Q1.

Under what circumstances would you prescribe Mounjaro over another medication?

Added By: max_admin
Q2.

What proportion of patients do you prescribe Mounjaro for?

Added By: max_admin
Q3.

On a scale of 1-10 how would you rate Mounjaro as an accessible option for treating type-2 Diabetes.

Added By: max_admin

Do you want answers to these questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.